Immunome, Inc.
IMNM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $622,751 | $212,327 | $26,800 | $149,541 |
| - Cash | $143,351 | $98,679 | $20,323 | $49,229 |
| + Debt | $4,832 | $1,650 | $291 | $317 |
| Enterprise Value | $484,232 | $115,298 | $6,768 | $100,629 |
| Revenue | $9,041 | $14,018 | $0 | $0 |
| % Growth | -35.5% | – | – | – |
| Gross Profit | $9,041 | $14,018 | $0 | $0 |
| % Margin | 100% | 100% | – | – |
| EBITDA | -$151,354 | -$28,000 | -$36,270 | -$24,449 |
| % Margin | -1,674.1% | -199.7% | – | – |
| Net Income | -$292,963 | -$106,806 | -$36,896 | -$24,711 |
| % Margin | -3,240.4% | -761.9% | – | – |
| EPS Diluted | -5 | -5.38 | -3.09 | -2.14 |
| % Growth | 7.1% | -74.1% | -44.4% | – |
| Operating Cash Flow | -$110,794 | -$7,568 | -$28,690 | -$18,226 |
| Capital Expenditures | -$53,508 | -$831 | -$248 | -$79 |
| Free Cash Flow | -$164,302 | -$8,399 | -$28,938 | -$18,305 |